-
Mechanisms of Antidepressant Action of Psilocybin: The Role of 5-HT2B-5-HT1A Receptor Dimerization and GSK-3β Activation...
Call: OPUS 27 , Panel: NZ7
Principal investigator: dr hab. Agata Faron-Górecka
Instytut Farmakologii PAN
-
Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista...
Call: OPUS 26 , Panel: NZ7
Principal investigator: prof. Mariusz Papp
Instytut Farmakologii PAN
-
Plasticity of neuroanatomically identified synaptic inputs and functions of the dorsal raphe nucleus in an animal model ...
Call: OPUS 25 , Panel: NZ4
Principal investigator: prof. Krzysztof Tokarski
Instytut Farmakologii PAN
-
Zinc deficient diet as a trigger for treatment-resistant depression in chronically stressed mice. Understanding the mech...
Call: OPUS 19 , Panel: NZ5
Principal investigator: dr hab. Bernadeta Szewczyk
Instytut Farmakologii PAN
-
Investigation of molecular mechanisms of rapid antidepressant action of NLX-101, a biased agonist of the 5-HT1A receptor...
Call: OPUS 18 , Panel: NZ7
Principal investigator: prof. Mariusz Papp
Instytut Farmakologii PAN
-
Pharmacological and optogenetic investigation of the mechanism of action of Deep Brain Stimulation of the ventromedial p...
Call: OPUS 13 , Panel: NZ7
Principal investigator: prof. Mariusz Papp
Instytut Farmakologii PAN
-
Investigation of the effects and mechanisms of action of Deep Brain Stimulation in two animal models of treatment-resist...
Call: OPUS 9 , Panel: NZ7
Principal investigator: prof. Mariusz Papp
Instytut Farmakologii PAN